Guidance document : fees for the review of human and disinfectant drug submissions and applications.: H13-9/18-2019E-PDF
"This document provides guidance on how fees for the review of human and disinfectant drug submissions and applications will be administered in accordance with the Food and Drugs Act and as stipulated in the Fees in Respect of Drugs and Medical Devices Order and the Regulations Amending and Repealing Certain Regulations Made under the Financial Administration Act"--Objectives, page 6.
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.859811&sl=0
Department/Agency | Canada. Health Canada, issuing body. |
---|---|
Title | Guidance document : fees for the review of human and disinfectant drug submissions and applications. |
Variant title | Fees for the review of human and disinfectant drug submissions and applications |
Publication type | Monograph |
Language | [English] |
Other language editions | [French] |
Format | Electronic |
Electronic document | |
Note(s) | Issued also in French under title: Ligne directrice : frais pour l'examen des présentations et des demandes de médicaments à usage humain et de désinfectants assimilés à une drogue. "Publication date: November 2019." "Pub.: 180194." Issued also in HTML format. |
Publishing information | Ottawa, ON : Health Canada = Santé Canada, 2019. ©2019 |
Description | 1 online resource (21 pages) |
ISBN | 9780660274355 |
Catalogue number |
|
Subject terms | Drug approval -- Canada. Fees, Administrative -- Canada. |